Skip to main content
Erschienen in: European Radiology 2/2016

01.02.2016 | Interventional

Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications

verfasst von: Mingyue Cai, Wensou Huang, Chaoshuang Lin, Zhengran Li, Jiesheng Qian, Mingsheng Huang, Zhaolin Zeng, Jingjun Huang, Hong Shan, Kangshun Zhu

Erschienen in: European Radiology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To investigate the predictors of platelet increment and risk factors for major complications after partial splenic embolization (PSE) in cirrhosis.

Methods

Between March 2010 and June 2012, 52 cirrhotic patients with severe thrombocytopenia underwent PSE. Multiple variables were analyzed to identify the correlated factors affecting platelet increment and major complications after PSE.

Results

Linear mixed model analysis indicated the splenic infarction ratio (P < 0.001), non-infarcted splenic volume (P = 0.012), and cholinesterase level (P < 0.001) were significantly associated with the platelet increment after PSE. In receiver operating characteristic (ROC) analysis, the cut-off values of the splenic infarction ratio, and non-infarcted splenic volume for achieving an increment of ≥60.0 × 109/L in platelet counts at 1 year after PSE were 64.3 % and 245.8 mL, respectively. After PSE, eight patients developed major complications. Multivariate logistic regression analysis indicated major complications were significantly associated with the infarcted splenic volume (P = 0.024) and Child-Pugh score (P = 0.018). In ROC analysis, the cut-off values of these two factors for discriminating the uncomplicated and complicated were 513.1 mL and 9.5, respectively.

Conclusions

The platelet increment after PSE depends on the splenic infarction ratio, non-infarcted splenic volume and cholinesterase level. But a large infarcted splenic volume and a high Child-Pugh score may cause complications.

Key Points

The platelet increment after PSE greatly depends on the splenic infarction ratio.
The non-infarcted splenic volume significantly affects the efficacy of PSE.
A high cholinesterase level contributes to the improvement of thrombocytopenia after PSE.
The non-infarcted splenic volume significantly affects the relapse of hypersplenism.
Complications are significantly associated with the infarcted splenic volume and Child-Pugh score.
Literatur
1.
Zurück zum Zitat Poordad F (2007) Review article: thrombocytopenia in chronic liver disease. Aliment Pharmacol Ther 26:5–11PubMedCrossRef Poordad F (2007) Review article: thrombocytopenia in chronic liver disease. Aliment Pharmacol Ther 26:5–11PubMedCrossRef
2.
Zurück zum Zitat Afdhal N, McHutchison J, Brown R et al (2008) Thrombocytopenia associated with chronic liver disease. J Hepatol 48:1000–1007PubMedCrossRef Afdhal N, McHutchison J, Brown R et al (2008) Thrombocytopenia associated with chronic liver disease. J Hepatol 48:1000–1007PubMedCrossRef
3.
Zurück zum Zitat Fouad YM (2013) Chronic hepatitis C-associated thrombocytopenia: aetiology and management. Trop Gastroenterol 34:58–67PubMedCrossRef Fouad YM (2013) Chronic hepatitis C-associated thrombocytopenia: aetiology and management. Trop Gastroenterol 34:58–67PubMedCrossRef
4.
Zurück zum Zitat Sangro B, Bilbao I, Herrero I et al (1993) Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology 18:309–314PubMedCrossRef Sangro B, Bilbao I, Herrero I et al (1993) Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology 18:309–314PubMedCrossRef
5.
Zurück zum Zitat Zhu K, Meng X, Li Z et al (2008) Partial splenic embolization using polyvinyl alcohol particles for hypersplenism in cirrhosis: a prospective randomized study. Eur J Radiol 66:100–106PubMedCrossRef Zhu K, Meng X, Li Z et al (2008) Partial splenic embolization using polyvinyl alcohol particles for hypersplenism in cirrhosis: a prospective randomized study. Eur J Radiol 66:100–106PubMedCrossRef
6.
Zurück zum Zitat Zhu K, Meng X, Qian J et al (2009) Partial splenic embolization for hypersplenism in cirrhosis: a long-term outcome in 62 patients. Dig Liver Dis 41:411–416PubMedCrossRef Zhu K, Meng X, Qian J et al (2009) Partial splenic embolization for hypersplenism in cirrhosis: a long-term outcome in 62 patients. Dig Liver Dis 41:411–416PubMedCrossRef
7.
Zurück zum Zitat Amin MA, El-Gendy MM, Dawoud IE, Shoma A, Negm AM, Amer TA (2009) Partial splenic embolization versus splenectomy for the management of hypersplenism in cirrhotic patients. World J Surg 33:1702–1710PubMedCrossRef Amin MA, El-Gendy MM, Dawoud IE, Shoma A, Negm AM, Amer TA (2009) Partial splenic embolization versus splenectomy for the management of hypersplenism in cirrhotic patients. World J Surg 33:1702–1710PubMedCrossRef
8.
Zurück zum Zitat Palsson B, Verbaan H (2005) Partial splenic embolization as pretreatment for antiviral therapy in hepatitis C virus infection. Eur J Gastroenterol Hepatol 17:1153–1155PubMedCrossRef Palsson B, Verbaan H (2005) Partial splenic embolization as pretreatment for antiviral therapy in hepatitis C virus infection. Eur J Gastroenterol Hepatol 17:1153–1155PubMedCrossRef
9.
Zurück zum Zitat Noguchi H, Hirai K, Aoki Y, Sakata K, Tanikawa K (1995) Changes in platelet kinetics after a partial splenic arterial embolization in cirrhotic patients with hypersplenism. Hepatology 22:1682–1688PubMedCrossRef Noguchi H, Hirai K, Aoki Y, Sakata K, Tanikawa K (1995) Changes in platelet kinetics after a partial splenic arterial embolization in cirrhotic patients with hypersplenism. Hepatology 22:1682–1688PubMedCrossRef
10.
Zurück zum Zitat Hayashi H, Beppu T, Masuda T et al (2007) Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patients. J Gastroenterol Hepatol 22:1638–1642PubMedCrossRef Hayashi H, Beppu T, Masuda T et al (2007) Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patients. J Gastroenterol Hepatol 22:1638–1642PubMedCrossRef
11.
Zurück zum Zitat Hayashi H, Beppu T, Okabe K et al (2010) Therapeutic factors considered according to the preoperative splenic volume for a prolonged increase in platelet count after partial splenic embolization for liver cirrhosis. J Gastroenterol 45:554–559PubMedCrossRef Hayashi H, Beppu T, Okabe K et al (2010) Therapeutic factors considered according to the preoperative splenic volume for a prolonged increase in platelet count after partial splenic embolization for liver cirrhosis. J Gastroenterol 45:554–559PubMedCrossRef
12.
Zurück zum Zitat N'Kontchou G, Seror O, Bourcier V et al (2005) Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients. Eur J Gastroenterol Hepatol 17:179–184PubMedCrossRef N'Kontchou G, Seror O, Bourcier V et al (2005) Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients. Eur J Gastroenterol Hepatol 17:179–184PubMedCrossRef
13.
Zurück zum Zitat Vujic I, Lauver JW (1981) Severe complications from partial splenic embolization in patients with liver failure. Br J Radiol 54:492–495PubMedCrossRef Vujic I, Lauver JW (1981) Severe complications from partial splenic embolization in patients with liver failure. Br J Radiol 54:492–495PubMedCrossRef
14.
Zurück zum Zitat Sakai T, Shiraki K, Inoue H et al (2002) Complications of partial splenic embolization in cirrhotic patients. Dig Dis Sci 47:388–391PubMedCrossRef Sakai T, Shiraki K, Inoue H et al (2002) Complications of partial splenic embolization in cirrhotic patients. Dig Dis Sci 47:388–391PubMedCrossRef
15.
Zurück zum Zitat Hayashi H, Beppu T, Okabe K, Masuda T, Okabe H, Baba H (2008) Risk factors for complications after partial splenic embolization for liver cirrhosis. Br J Surg 95:744–750PubMedCrossRef Hayashi H, Beppu T, Okabe K, Masuda T, Okabe H, Baba H (2008) Risk factors for complications after partial splenic embolization for liver cirrhosis. Br J Surg 95:744–750PubMedCrossRef
16.
Zurück zum Zitat Cai M, Zhu K, Huang W et al (2013) Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up. J Vasc Interv Radiol 24:1808–1816PubMedCrossRef Cai M, Zhu K, Huang W et al (2013) Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up. J Vasc Interv Radiol 24:1808–1816PubMedCrossRef
17.
Zurück zum Zitat Alwmark A, Bengmark S, Gullstrand P, Joelsson B, Lunderquist A, Owman T (1982) Evaluation of splenic embolization in patients with portal hypertension and hypersplenism. Ann Surg 196:518–524PubMedPubMedCentralCrossRef Alwmark A, Bengmark S, Gullstrand P, Joelsson B, Lunderquist A, Owman T (1982) Evaluation of splenic embolization in patients with portal hypertension and hypersplenism. Ann Surg 196:518–524PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Koizumi J, Itou C, Wray R et al (2013) Partial splenic embolisation using n-butyl cyanoacrylate: intraprocedural evaluation by magnetic resonance imaging. Eur Radiol 23:1429–1442PubMedCrossRef Koizumi J, Itou C, Wray R et al (2013) Partial splenic embolisation using n-butyl cyanoacrylate: intraprocedural evaluation by magnetic resonance imaging. Eur Radiol 23:1429–1442PubMedCrossRef
19.
Zurück zum Zitat Hidaka H, Kokubu S, Saigenji K, Isobe Y, Maeda T (2002) Restoration of thrombopoietin production after partial splenic embolization leads to resolution of thrombocytopenia in liver cirrhosis. Hepatol Res 23:265PubMedCrossRef Hidaka H, Kokubu S, Saigenji K, Isobe Y, Maeda T (2002) Restoration of thrombopoietin production after partial splenic embolization leads to resolution of thrombocytopenia in liver cirrhosis. Hepatol Res 23:265PubMedCrossRef
20.
Zurück zum Zitat Angle JF, Siddiqi NH, Wallace MJ et al (2010) Quality improvement guidelines for percutaneous transcatheter embolization: Society of Interventional Radiology Standards of Practice Committee. J Vasc Interv Radiol 21:1479–1486PubMedCrossRef Angle JF, Siddiqi NH, Wallace MJ et al (2010) Quality improvement guidelines for percutaneous transcatheter embolization: Society of Interventional Radiology Standards of Practice Committee. J Vasc Interv Radiol 21:1479–1486PubMedCrossRef
21.
Zurück zum Zitat Meng F, Yin X, Ma X, Guo XD, Jin B, Li H (2013) Assessment of the value of serum cholinesterase as a liver function test for cirrhotic patients. Biomed Rep 1:265–268PubMedPubMedCentral Meng F, Yin X, Ma X, Guo XD, Jin B, Li H (2013) Assessment of the value of serum cholinesterase as a liver function test for cirrhotic patients. Biomed Rep 1:265–268PubMedPubMedCentral
Metadaten
Titel
Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications
verfasst von
Mingyue Cai
Wensou Huang
Chaoshuang Lin
Zhengran Li
Jiesheng Qian
Mingsheng Huang
Zhaolin Zeng
Jingjun Huang
Hong Shan
Kangshun Zhu
Publikationsdatum
01.02.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 2/2016
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-015-3839-4

Weitere Artikel der Ausgabe 2/2016

European Radiology 2/2016 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.